Medigen Overview

  • Founded
  • 2004
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $4.73M
Latest Deal Amount
  • Investors
  • 4

Medigen General Information


Developer of vaccines intended to fight against diseases. The company's vaccines are developed applying scientific knowledge of viruses, processes and immune systems to discover, develop and commercialize new biopharmaceutical products, enabling patients to get treatment and prevention of emerging infections and chronic diseases including cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 8420 Gas House Pike
  • Suite S
  • Frederick, MD 21701
  • United States
+1 (301) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2018 $4.73M Completed Generating Revenue
1. Accelerator/Incubator 30-May-2013 Completed Generating Revenue
To view Medigen’s complete valuation and funding history, request access »

Medigen Executive Team (1)

Name Title Board Seat Contact Info
Peter Pushko MD Founder, President & Chief Scientific Officer
To view Medigen’s complete executive team members history, request access »

Medigen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
United States Department of Agriculture Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Frederick Innovative Technology Center Accelerator/Incubator Minority 000 0000 000000 0
To view Medigen’s complete investors history, request access »

Medigen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 01-Jan-2004 000000000000000000 Other Pharmaceuticals and Biotechnology
To view Medigen’s complete acquisitions history, request access »

Medigen Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 0000000 01-Jan-2004 000000000000000000 Completed
  • 0000000
To view Medigen’s complete exits history, request access »